Sanofi India Reports Strong Financial Results Amid Mixed Operational Indicators in March 2025

Sanofi India has recently reported its financial results for the quarter ending March 2025, showcasing notable developments within the company's performance metrics. The evaluation changes reflect a significant shift, with the score moving to 7 from -1 over the past three months.
The financial results indicate a robust performance in several key areas. Profit Before Tax less Other Income (PBT) reached Rs 162.00 crore, marking a substantial growth compared to the average of the previous four quarters. Additionally, the company achieved its highest Operating Cash Flow in three years, totaling Rs 461.70 crore, indicating strong cash generation from operations. Net Sales also hit a five-quarter high at Rs 535.90 crore, alongside an Operating Profit of Rs 171.90 crore, which is the highest recorded in the same timeframe. The Operating Profit Margin improved to 32.08%, reflecting enhanced operational efficiency.

However, not all aspects are favorable. The Debtors Turnover Ratio has declined to 8.75 times, indicating a slower pace in settling debts. Furthermore, the Dividend per Share has reached its lowest point in five years at Rs 117.00, suggesting a reduction in shareholder returns compared to previous years.

For more insights on Sanofi India's financial trends and performance, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.